News

News-Medical.Net11h
Qureight analyze of Insilico Medicine's Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical ...